This course is produced for all. Unauthorised duplication is prohibited. The content is for educational purposes only. It is not treatment advice or medical advice. It may contain errors of fact or omission. Stroke medicine changes constantly so this may not be up to date and may contain errors. If you need medical advice, please consult a doctor or other appropriate medical professional. If you are a medical professional and you need advice then speak to your senior or colleagues.

Welcome and Introduction

Latest news and Developments

November 2015:Mechanical Thrombectomy

Currently in the UK and I am sure Worldwide, delivering Mechanical thrombectomy is the current focus of attention and the challenge is to deliver robust clinical pathways to allow it to be offered to stroke patients quickly and safely. Here is an interesting paper from 2012 and here is Consensus statement from the European Stroke Organisation. It will be interesting times ahead. Here is an interesting read the PISTE or Pragmatic Ischaemic Stroke Thrombectomy Evaluation study run by Keith Muir. For those not aware of the typical selection criteria it will be those age >18 years with NIHSS ≥ 6 and No Major Contraindication and Eligible for IV rtPA who will be given standard IV rtPA 0.9mg/kg and then either MRA/CTA/DSA looking for ICA-T, MCA M1 or M2 occlusion and then randomized to receive completion of alteplase or Additional mechanical thrombectomy IA Device selected as per Neurointerventionalist. Assessment will be early major neurological improvement as per NIHSS and mRS at 3m.

I know large teaching centres are getting on with their plans and are at varying stages. It is going to be a significant amount of additional work for a tertiary centre in a time when there is no money to go around. Do we need to go down the route of the cardiology PCI model. Should I be asking my cardiology colleagues to go north.

free web counter